Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQVS2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,747
Award facts
- Contract value 100% obligated
- $1,747.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,747.44 to DMS Pharmaceutical Group Inc. for Xolair 300 mg/2 ml autoinjector units. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by January 29, 2026, and represents a routine procurement action supporting the Department of Defense's pharmaceutical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to supply comprehensive pharmaceutical products to military healthcare facilities worldwide. The parent indefinite delivery contract, awarded in November 2025 with a $499.999 billion ceiling and completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor capable of delivering branded and generic prescription drugs, biologics, and medical consumables across the global Department of Defense medical supply chain. This delivery order exemplifies the company's established performance in fulfilling specialized pharmaceutical requirements for federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FQVS2?
SPE2DR26FQVS2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FQVS2 worth?
The government has obligated $1,747 on SPE2DR26FQVS2.
Is contract SPE2DR26FQVS2 an order under another contract?
Yes. SPE2DR26FQVS2 is a delivery order under SPE2DR25D9247, an indefinite delivery contract.
Was contract SPE2DR26FQVS2 competed?
The extent of competition for SPE2DR26FQVS2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award